AI Leaders' Takes

Public

NeoDrop Official

Weekly digest of public statements from top AI lab founders and chief scientists across multiple channels

AI Leaders' Takes2026-07-06

AI Leaders Weekly: Equity Politics

This week’s issue argues that AI leadership discourse shifted from benchmark competition toward state alignment, access control, and infrastructure politics. It contrasts Altman’s proposed public-equity bargain with Anthropic’s safeguards-and-redeployment path, then places Huang, Mistral, Meta, xAI, DeepMind, LeCun, and SSI into the same strategic frame for AI strategists and PMs.

AI Leaders' Takes2026-06-29

AI Leaders Weekly: The Approval Regime

This week’s issue centers on the emergence of a working approval regime for frontier AI model access: Anthropic’s Mythos 5 was partially cleared for selected US institutions while Fable 5 stayed restricted, and OpenAI’s GPT-5.6 release was reported as limited to government-approved trusted partners. The article also covers Altman’s security-product updates, Musk’s Grok 4.5 cadence claim, DeepMind’s Gemini 3.5 Pro delay and Computer Use launch, and Jensen Huang’s framing of AI adoption as a social and industrial transition.

AI Leaders' Takes2026-06-22

AI Leaders Weekly: The Coalition and the Ban

The June 8–22 window was organized around a single structural tension: four AI lab chiefs flew to the G7 in Évian to propose US-led AI governance — and sat across from the officials who had just banned Anthropic's flagship models worldwide. The two-week period also brought the two highest-profile talent moves of 2026: Noam Shazeer to OpenAI and Nobel laureate John Jumper to Anthropic — both exits from Google DeepMind. Plus Yann LeCun's world models pitch at VivaTech, Ilya Sutskever's first signal in six weeks, and Arthur Mensch's sovereignty moment.

AI Leaders' Takes2026-06-08

AI Leaders Weekly: Four CEOs, one biosecurity bill

The week's defining event was a June 4 open letter signed jointly by Altman, Amodei, Hassabis, and Suleyman urging Congress to mandate synthetic DNA/RNA screening — the most concrete regulatory alignment yet among competing AI lab heads. Jensen Huang ran a four-day Seoul physical-AI summit culminating in a gigawatt-scale Naver cloud deal and an announced Seoul R&D center. Anthropic filed a confidential S-1 with a $47B revenue run rate; Hassabis placed AGI at "maybe 2030" at Stanford; Suleyman declared intent to eliminate Microsoft's Anthropic spending while launching seven in-house models.

AI Leaders' Takes2026-06-01

AI Leaders Weekly: May 25–June 1, 2026

The week's defining story: Sam Altman and Dario Amodei both walked back their "AI jobs apocalypse" predictions within the same 7-day window, as OpenAI and Anthropic approach blockbuster IPOs at a combined near-$2 trillion in reported valuation. Jensen Huang unveiled the N1X — NVIDIA's first Windows ARM PC chip — while anchoring $100B in annual Taiwan spend. Demis Hassabis framed the current agentic era as a "practice run" for AGI and closed a $2.1B Series B for Isomorphic Labs. Arthur Mensch defied the Pope on military AI, announced custom chip exploration, and signed Airbus.

AI Leaders' Takes2026-05-25

AI Leaders Weekly: May 18–25, 2026

A week where "agentic AI has arrived" went from forecast to stated fact: NVIDIA's $81.6B quarter, OpenAI's model solving an 80-year math conjecture, and Demis Hassabis declaring "we're at the foothills of the singularity." Plus Amodei and Daniela on Oprah, Suleyman's 18-month white-collar automation call, Arthur Mensch's Europe sovereignty warning, and four cross-cutting strategic signals for AI PMs.

AI Leaders' Takes2026-05-15

AI Leaders Weekly: May 8–15, 2026

A weekly digest covering seven AI leaders (May 8–15): Altman testifies in the Musk trial while running a concentrated Codex push; Jensen Huang addresses AI's labor impact at CMU then heads to Beijing; Amodei publishes a US-China geopolitics paper; Hassabis closes Isomorphic Labs' $2.1B raise; Sutskever testifies against his former CEO; plus Socher's $650M raise, xAI→SpaceXAI, and Mistral's sovereignty testimony.

No more Posts

View full content archive